BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 34148071)

  • 1. Annexin A1 restores cerebrovascular integrity concomitant with reduced amyloid-β and tau pathology.
    Ries M; Watts H; Mota BC; Lopez MY; Donat CK; Baxan N; Pickering JA; Chau TW; Semmler A; Gurung B; Aleksynas R; Abelleira-Hervas L; Iqbal SJ; Romero-Molina C; Hernandez-Mir G; d'Amati A; Reutelingsperger C; Goldfinger MH; Gentleman SM; Van Leuven F; Solito E; Sastre M
    Brain; 2021 Jun; 144(5):1526-1541. PubMed ID: 34148071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annexin A1 restores Aβ
    Park JC; Baik SH; Han SH; Cho HJ; Choi H; Kim HJ; Choi H; Lee W; Kim DK; Mook-Jung I
    Aging Cell; 2017 Feb; 16(1):149-161. PubMed ID: 27633771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anti-inflammatory Annexin A1 induces the clearance and degradation of the amyloid-β peptide.
    Ries M; Loiola R; Shah UN; Gentleman SM; Solito E; Sastre M
    J Neuroinflammation; 2016 Sep; 13(1):234. PubMed ID: 27590054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crocus sativus Extract Tightens the Blood-Brain Barrier, Reduces Amyloid β Load and Related Toxicity in 5XFAD Mice.
    Batarseh YS; Bharate SS; Kumar V; Kumar A; Vishwakarma RA; Bharate SB; Kaddoumi A
    ACS Chem Neurosci; 2017 Aug; 8(8):1756-1766. PubMed ID: 28471166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversing pathology in a preclinical model of Alzheimer's disease by hacking cerebrovascular neoangiogenesis with advanced cancer therapeutics.
    Singh CSB; Choi KB; Munro L; Wang HY; Pfeifer CG; Jefferies WA
    EBioMedicine; 2021 Sep; 71():103503. PubMed ID: 34534764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-malaria drug artesunate prevents development of amyloid-β pathology in mice by upregulating PICALM at the blood-brain barrier.
    Kisler K; Sagare AP; Lazic D; Bazzi S; Lawson E; Hsu CJ; Wang Y; Ramanathan A; Nelson AR; Zhao Z; Zlokovic BV
    Mol Neurodegener; 2023 Jan; 18(1):7. PubMed ID: 36707892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of an essential endogenous regulator of blood-brain barrier integrity, and its pathological and therapeutic implications.
    Cristante E; McArthur S; Mauro C; Maggioli E; Romero IA; Wylezinska-Arridge M; Couraud PO; Lopez-Tremoleda J; Christian HC; Weksler BB; Malaspina A; Solito E
    Proc Natl Acad Sci U S A; 2013 Jan; 110(3):832-41. PubMed ID: 23277546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Hit Compounds Identified from High-throughput Screening for their Effect on Blood-brain Barrier Integrity and Amyloid-β Clearance: In Vitro and In Vivo Studies.
    Elfakhri KH; Duong QV; Langley C; Depaula A; Mousa YM; Lebeouf T; Cain C; Kaddoumi A
    Neuroscience; 2018 May; 379():269-280. PubMed ID: 29596966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
    Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
    J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired Amyloid Beta Clearance and Brain Microvascular Dysfunction are Present in the Tg-SwDI Mouse Model of Alzheimer's Disease.
    Rosas-Hernandez H; Cuevas E; Raymick JB; Robinson BL; Sarkar S
    Neuroscience; 2020 Aug; 440():48-55. PubMed ID: 32450297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LPS priming before plaque deposition impedes microglial activation and restrains Aβ pathology in the 5xFAD mouse model of Alzheimer's disease.
    Yang Y; García-Cruzado M; Zeng H; Camprubí-Ferrer L; Bahatyrevich-Kharitonik B; Bachiller S; Deierborg T
    Brain Behav Immun; 2023 Oct; 113():228-247. PubMed ID: 37437821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
    Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
    Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dickkopf-related protein-1 inhibition attenuates amyloid-beta pathology associated to Alzheimer's disease.
    Menet R; Bourassa P; Calon F; ElAli A
    Neurochem Int; 2020 Dec; 141():104881. PubMed ID: 33068684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oleocanthal-rich extra-virgin olive oil enhances donepezil effect by reducing amyloid-β load and related toxicity in a mouse model of Alzheimer's disease.
    Batarseh YS; Kaddoumi A
    J Nutr Biochem; 2018 May; 55():113-123. PubMed ID: 29413486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological changes induced by Alzheimer's brain inoculation in amyloid-beta plaque-bearing mice.
    Lam S; Hérard AS; Boluda S; Petit F; Eddarkaoui S; Cambon K; ; Picq JL; Buée L; Duyckaerts C; Haïk S; Dhenain M
    Acta Neuropathol Commun; 2022 Aug; 10(1):112. PubMed ID: 35974399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased tauopathy drives microglia-mediated clearance of beta-amyloid.
    Chen W; Abud EA; Yeung ST; Lakatos A; Nassi T; Wang J; Blum D; Buée L; Poon WW; Blurton-Jones M
    Acta Neuropathol Commun; 2016 Jun; 4(1):63. PubMed ID: 27339073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid β Oligomers Disrupt Blood-CSF Barrier Integrity by Activating Matrix Metalloproteinases.
    Brkic M; Balusu S; Van Wonterghem E; Gorlé N; Benilova I; Kremer A; Van Hove I; Moons L; De Strooper B; Kanazir S; Libert C; Vandenbroucke RE
    J Neurosci; 2015 Sep; 35(37):12766-78. PubMed ID: 26377465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease.
    Paouri E; Tzara O; Zenelak S; Georgopoulos S
    J Alzheimers Dis; 2017; 60(1):165-181. PubMed ID: 28826177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (-)-Oleocanthal Nutraceuticals for Alzheimer's Disease Amyloid Pathology: Novel Oral Formulations, Therapeutic, and Molecular Insights in 5xFAD Transgenic Mice Model.
    Tajmim A; Cuevas-Ocampo AK; Siddique AB; Qusa MH; King JA; Abdelwahed KS; Sonju JJ; El Sayed KA
    Nutrients; 2021 May; 13(5):. PubMed ID: 34069842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer's disease.
    Puntambekar SS; Moutinho M; Lin PB; Jadhav V; Tumbleson-Brink D; Balaji A; Benito MA; Xu G; Oblak A; Lasagna-Reeves CA; Landreth GE; Lamb BT
    Mol Neurodegener; 2022 Jun; 17(1):47. PubMed ID: 35764973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.